If organizations lack the necessary skills and resources, maintenance and management of the tools and technologies, along with training and uplift to support their OT and critical infrastructures, they risk increased and protracted downtime.
Internet…
Mass layoffs at the U.S. Department of Health and Human Services (HHS), including the Food and Drug Administration (FDA), will impact the medical device regulatory process, says Ben Wolf, partner in Alston & Bird’s…
Continue Reading
Mark Koeniguer, Chief Commercial Officer at iCAD
What You Should Know:
– iCAD, Inc., a provider of clinically proven AI-powered breast health solutions, today announced the appointment of Mark Koeniguer as its Chief Commercial Officer (CCO).
–…
Continue Reading
Source: MyPhenome genetic obesity test
What You Should Know:
– Phenomix Sciences (Phenomix), a commercial precision obesity medicine biotechnology company, today announced the initiation of its first prospective, placebo-controlled clinical study.
– The research will evaluate…
Continue Reading
Richard Samuel held leading operations and strategy roles in the NHS, and was formerly NHS England Director and NHS Chief Executive. Now at EBO, he believes AI can make healthcare more efficient, personalised and…
Continue Reading
Digital tools, including a patient optimisation eForm and a hospice data feed, have been launched in Kent to help improve prehabilitation and elective recovery.
The patient optimisation eForm was introduced in March 2025 to provide…
AI is the theme of the clinical-facing health tech track in the INVEST Pitch Perfect contest, scheduled to take place at the Willis Tower in Chicago from May 20-21. Among the investor judges for…
Continue Reading
The government and the Wellcome Trust will invest up to £600 million to create a Health Data Research Service, prime minister Sir Keir Starmer has announced.
It will bring access to data for medical research…
Digital phenotyping collects health data digitally, supporting early disease diagnosis and health management. This paper systematically reviews the diversity of research methods in digital phenotyping and its clinical benefits, while also focusing on its…
Continue Reading
Mark Newman, CEO of Nomi Health
Doctors aren’t just healers—they’re involuntary lenders. Every time a physician treats a patient, they’re fronting the cost of care and hoping to get reimbursed. If the insurer underpays or…
Continue Reading
